Business Development in Biotech – a competitive advantage?
Many biotech companies start as an idea for an idea: a business possibility for some scientific idea, often in embryonic stage. Their survival as companies and growth relies on the quality of the science but to a great extent on the team… Open Expert File
Avoiding the acquisition curse
Surveys show that, in average, mergers and acquisitions destroy value. Highly publicized successes are not sufficient to compensate for disastrous operations. Yet, it is relatively easy to set the rules of good acquisition practices… Open Expert File
Author: Olivier Pujol – COO – France